Brief: Seegene Continues To Support Israel's Effort To Manage The Omicron Variant With Timely Delivery Of Five Million Tests
17/01/2022 12:04
Jan 17 (Reuters) - Seegene Inc 096530.KQ :
* SEEGENE CONTINUES TO SUPPORT ISRAEL'S EFFORT TO MANAGE THE
OMICRON VARIANT WITH TIMELY DELIVERY OF FIVE MILLION TESTS
Source text for Eikon: ID:nCNWdrkPSa
Further company coverage: 096530.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier